Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Assertio Holdings - 28 Year Stock Price History | ASRT

Historical daily share price chart and data for Assertio Holdings since 1997 adjusted for splits and dividends. The latest closing stock price for Assertio Holdings as of July 02, 2025 is 0.67.
  • The all-time high Assertio Holdings stock closing price was 133.12 on July 21, 2015.
  • The Assertio Holdings 52-week high stock price is 1.80, which is 168.7% above the current share price.
  • The Assertio Holdings 52-week low stock price is 0.51, which is 23.9% below the current share price.
  • The average Assertio Holdings stock price for the last 52 weeks is 0.94.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Assertio Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 0.7154 0.8501 0.8845 0.5341 0.6748 -22.53%
2024 1.0556 1.1400 1.7500 0.7540 0.8711 -18.59%
2023 4.1785 4.1700 7.6600 1.0200 1.0700 -75.12%
2022 2.8045 2.6500 4.3000 1.8800 4.3000 97.25%
2021 1.9187 1.7600 4.8800 0.8600 2.1800 52.40%
2020 3.2357 4.7600 6.0800 1.3600 1.4304 -71.39%
2019 11.3262 15.9200 22.6400 2.8148 5.0000 -65.37%
2018 26.3328 34.1200 37.3200 14.1200 14.4400 -55.16%
2017 42.2313 81.3600 85.2400 18.2400 32.2000 -55.33%
2016 75.9667 72.6400 104.0400 51.9600 72.0800 -0.61%
2015 90.6560 64.2000 133.1200 61.6400 72.5200 12.54%
2014 54.1928 42.3200 65.4800 39.8000 64.4400 52.27%
2013 26.8634 25.5200 42.3600 20.5200 42.3200 70.92%
2012 23.2522 21.4000 28.2400 19.8800 24.7600 19.50%
2011 28.0411 26.0800 40.1600 17.0400 20.7200 -18.55%
2010 15.2820 12.8400 26.2400 9.4800 25.4400 89.85%
2009 11.5814 7.1200 25.4400 6.8000 13.4000 103.03%
2008 12.6084 13.1200 17.6800 4.0800 6.6000 -49.39%
2007 12.6334 14.0000 20.0400 7.0000 13.0400 -5.51%
2006 20.9965 23.7200 28.0800 11.8000 13.8000 -42.50%
2005 19.4009 21.6000 26.8000 13.8400 24.0000 11.11%
2004 24.0567 28.8800 35.4800 15.4800 21.6000 -23.84%
2003 18.5444 8.0000 31.5200 8.0000 28.3600 254.50%
2002 14.6492 27.4000 28.8400 4.5600 8.0000 -71.01%
2001 19.4490 16.5000 28.0000 12.8000 27.6000 57.71%
2000 17.3659 22.0000 33.2500 10.2500 17.5000 -27.08%
1999 21.9573 33.0000 56.0000 8.0000 24.0000 -23.81%
1998 39.3350 17.0000 57.0000 16.0000 31.5000 85.29%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.061B $0.125B
Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc., is based in LAKE FOREST, Ill.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $82.473B 30.94
Zoetis (ZTS) United States $70.873B 26.44
Takeda Pharmaceutical (TAK) Japan $48.906B 9.73
Daiichi Sankyo, - (DSNKY) Japan $43.589B 22.34
BeOne Medicines - (ONC) Cayman Islands $26.870B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.896B 0.00
Merck (MKKGY) Germany $17.128B 12.55
Summit Therapeutics (SMMT) United States $15.745B 0.00
Shionogi (SGIOY) Japan $15.040B 15.07
United Therapeutics (UTHR) United States $13.122B 11.61
Neurocrine Biosciences (NBIX) United States $12.668B 43.39
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $10.061B 0.00
Stevanato Group S.p.A (STVN) Italy $7.511B 45.93
Corcept Therapeutics (CORT) United States $7.350B 59.75
Madrigal Pharmaceuticals (MDGL) United States $6.665B 0.00
Ionis Pharmaceuticals (IONS) United States $6.357B 0.00
Grifols, S.A (GRFS) Spain $6.188B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.164B 0.00
Hypermarcas (HYPMY) Brazil $3.059B 20.12
Crinetics Pharmaceuticals (CRNX) United States $2.662B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.585B 9.06
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.573B 13.91
NewAmsterdam Pharma (NAMS) Netherlands $2.046B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.883B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.759B 0.00
Endo (NDOI) United States $1.585B 0.00
ARS Pharmaceuticals (SPRY) United States $1.580B 0.00
Evotec AG (EVO) Germany $1.499B 0.00
Ocular Therapeutix (OCUL) United States $1.450B 0.00
Guardian Pharmacy Services (GRDN) United States $1.354B 0.00
Harrow (HROW) United States $1.129B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.011B 20.22
Verve Therapeutics (VERV) United States $1.006B 0.00
Dyne Therapeutics (DYN) United States $0.987B 0.00
Collegium Pharmaceutical (COLL) United States $0.974B 5.25
Enliven Therapeutics (ELVN) United States $0.964B 0.00
Akebia Therapeutics (AKBA) United States $0.938B 0.00
Ardelyx (ARDX) United States $0.933B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.852B 0.00
Cronos Group (CRON) Canada $0.741B 0.00
Xeris Biopharma Holdings (XERS) United States $0.729B 0.00
Elite Pharmaceuticals (ELTP) United States $0.717B 0.00
Relay Therapeutics (RLAY) United States $0.603B 0.00
USANA Health Sciences (USNA) United States $0.594B 12.91
KalVista Pharmaceuticals (KALV) United States $0.576B 0.00
Xencor (XNCR) United States $0.574B 0.00
Bioventus (BVS) United States $0.573B 14.52
Amylyx Pharmaceuticals (AMLX) United States $0.571B 0.00
Theravance Biopharma (TBPH) United States $0.546B 0.00
Zevra Therapeutics (ZVRA) United States $0.489B 0.00
Organogenesis (ORGO) United States $0.480B 0.00
Siga Technologies (SIGA) United States $0.464B 9.69
Oruka Therapeutics (ORKA) United States $0.442B 0.00
AleAnna (ANNA) United States $0.420B 0.00
Tourmaline Bio (TRML) United States $0.407B 0.00
Savara (SVRA) United States $0.354B 0.00
Altimmune (ALT) United States $0.343B 0.00
Aquestive Therapeutics (AQST) United States $0.338B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.334B 9.04
Heron Therapeutics (HRTX) United States $0.331B 0.00
Nektar Therapeutics (NKTR) United States $0.305B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.274B 0.00
Nature's Sunshine Products (NATR) United States $0.274B 25.17
Liminatus Pharma (LIMN) United States $0.269B 0.00
Aldeyra Therapeutics (ALDX) United States $0.235B 0.00
Nanobiotix S.A (NBTX) France $0.215B 0.00
OmniAb (OABI) United States $0.213B 0.00
MediWound (MDWD) Israel $0.208B 0.00
Esperion Therapeutics (ESPR) United States $0.198B 0.00
4D Molecular Therapeutics (FDMT) United States $0.192B 0.00
Larimar Therapeutics (LRMR) United States $0.184B 0.00
Profound Medical (PROF) Canada $0.183B 0.00
ProKidney (PROK) United States $0.165B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Journey Medical (DERM) United States $0.162B 0.00
Aclaris Therapeutics (ACRS) United States $0.153B 0.00
Inhibikase Therapeutics (IKT) United States $0.145B 0.00
Galectin Therapeutics (GALT) United States $0.141B 0.00
Lexeo Therapeutics (LXEO) United States $0.140B 0.00
Lyell Immunopharma (LYEL) United States $0.140B 0.00
Avita Medical (RCEL) United States $0.139B 0.00
Korro Bio (KRRO) United States $0.120B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.114B 0.00
Cardiol Therapeutics (CRDL) Canada $0.109B 0.00
Protara Therapeutics (TARA) United States $0.108B 0.00
VAXART, INC (VXRT) United States $0.105B 0.00
Champions Oncology (CSBR) United States $0.100B 16.39
Nutriband (NTRB) United States $0.089B 0.00
Cassava Sciences (SAVA) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.088B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Fractyl Health (GUTS) United States $0.077B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Achieve Life Sciences (ACHV) Canada $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Surrozen (SRZN) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Rafael Holdings (RFL) United States $0.068B 0.00
Pyxis Oncology (PYXS) United States $0.067B 0.00
Wellgistics Health (WGRX) United States $0.065B 0.00
Inotiv (NOTV) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.057B 0.00
Context Therapeutics (CNTX) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.056B 0.00
PMV Pharmaceuticals (PMVP) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.78
Gain Therapeutics (GANX) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Prelude Therapeutics (PRLD) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Telomir Pharmaceuticals (TELO) United States $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Klotho Neurosciences (KLTO) United States $0.034B 0.00
Jupiter Neurosciences (JUNS) United States $0.033B 0.00
China SXT Pharmaceuticals (SXTC) China $0.030B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
VYNE Therapeutics (VYNE) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Vivos Therapeutics (VVOS) United States $0.023B 0.00
FibroGen (FGEN) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
BioVie (BIVI) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Scienture Holdings (SCNX) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.04
Cosmos Health (COSM) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.57
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00